Seeing Is Believing

Currently out of the existing stock ratings of Christopher Howe, 91 are a BUY (93.81%), 6 are a HOLD (6.19%).
Analyst Christopher Howe, carries an average stock price target met ratio of 56.24% that have a potential upside of 33.25% achieved within 283 days. Previously, Christopher Howe worked at BARRINGTON, B. RILEY.
Christopher Howe’s has documented 194 price targets and ratings displayed on 17 stocks. The coverage was on Technology, Industrials, Consumer Cyclical, Basic Materials, Healthcare sectors.
Most recent stock forecast was given on SRT, StarTek at 10-Oct-2023.
Analyst best performing recommendations are on SRTS (SENSUS HEALTHCARE).
The best stock recommendation documented was for CALX (CALIX) at 10/26/2021. The price target of $73 was fulfilled within 13 days with a profit of $14.93 (25.71%) receiving and performance score of 19.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Apr-2022
$55
$19.04 (52.95%)
$55
1 months 19 days ago
(23-Jul-2026)
12/30 (40%)
$19.23 (53.76%)
219
Buy Since 16-Apr-2026
$58
$22.04 (61.29%)
$65
1 months 20 days ago
(22-Jul-2026)
6/11 (54.55%)
$22.16 (61.83%)
31
Hold Since 21-Jul-2026
$52
$16.04 (44.61%)
$52
1 months 21 days ago
(21-Jul-2026)
12/16 (75%)
$13.65 (35.59%)
230
Buy Since 22-Jun-2021
$62
$26.04 (72.41%)
$70
4 months 19 days ago
(23-Apr-2026)
17/30 (56.67%)
$19.31 (45.23%)
185
Buy Since 29-Jan-2022
$75
$39.04 (108.57%)
$68
10 months 11 days ago
(31-Oct-2025)
14/15 (93.33%)
$6.58 (9.62%)
369